Literature DB >> 17045809

A functional FERM domain binding motif in neurofascin.

Frank J Gunn-Moore1, Maria Hill, Fleur Davey, Lissa R Herron, Steven Tait, Diane Sherman, Peter J Brophy.   

Abstract

The L1 family of transmembrane cell adhesion receptors are involved in the development of the nervous system and consist of L1, neuron-glial-related cell adhesion molecule and neurofascin. All three receptors have a short cytoplasmic tail which is known to bind to the cytoskeletal associated protein ankyrin. Ezrin is a cytoplasmic binding protein known to link plasma membrane proteins to the cytoskeleton and has been shown to be a binding partner for L1. Here we show that neurofascin can also interact directly with ezrin. However, the mechanism of interaction of L1 and neurofascin with ezrin is by different mechanisms. We also show that the neurofascin isoform, Nfasc155, co-localizes with ezrin in transfected HEK293 cells but also in interdigitating Schwann cells at the node of Ranvier.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17045809     DOI: 10.1016/j.mcn.2006.09.003

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  11 in total

1.  Long-term maintenance of Na+ channels at nodes of Ranvier depends on glial contact mediated by gliomedin and NrCAM.

Authors:  Veronique Amor; Konstantin Feinberg; Yael Eshed-Eisenbach; Anya Vainshtein; Shahar Frechter; Martin Grumet; Jack Rosenbluth; Elior Peles
Journal:  J Neurosci       Date:  2014-04-09       Impact factor: 6.167

Review 2.  "CRASH"ing with the worm: insights into L1CAM functions and mechanisms.

Authors:  Lihsia Chen; Shan Zhou
Journal:  Dev Dyn       Date:  2010-05       Impact factor: 3.780

3.  unc-44 Ankyrin and stn-2 gamma-syntrophin regulate sax-7 L1CAM function in maintaining neuronal positioning in Caenorhabditis elegans.

Authors:  Shan Zhou; Karla Opperman; Xuelin Wang; Lihsia Chen
Journal:  Genetics       Date:  2008-09-14       Impact factor: 4.562

Review 4.  Myelination and regional domain differentiation of the axon.

Authors:  Courtney Thaxton; Manzoor A Bhat
Journal:  Results Probl Cell Differ       Date:  2009

5.  A central role for Necl4 (SynCAM4) in Schwann cell-axon interaction and myelination.

Authors:  Ivo Spiegel; Konstantin Adamsky; Yael Eshed; Ron Milo; Helena Sabanay; Offra Sarig-Nadir; Ido Horresh; Steven S Scherer; Matthew N Rasband; Elior Peles
Journal:  Nat Neurosci       Date:  2007-06-03       Impact factor: 24.884

6.  Neurofascin 140 is an embryonic neuronal neurofascin isoform that promotes the assembly of the node of Ranvier.

Authors:  Ao Zhang; Anne Desmazieres; Barbara Zonta; Shona Melrose; Graham Campbell; Don Mahad; Qiushi Li; Diane L Sherman; Richard Reynolds; Peter J Brophy
Journal:  J Neurosci       Date:  2015-02-04       Impact factor: 6.167

Review 7.  Willing to Be Involved in Cancer.

Authors:  Frank J Gunn-Moore; Andrew M Tilston-Lünel; Paul A Reynolds
Journal:  Genes (Basel)       Date:  2016-07-18       Impact factor: 4.096

8.  Optimal myelin elongation relies on YAP activation by axonal growth and inhibition by Crb3/Hippo pathway.

Authors:  Ruani N Fernando; Laurent Cotter; Claire Perrin-Tricaud; Jade Berthelot; Sylvain Bartolami; Jorge A Pereira; Sergio Gonzalez; Ueli Suter; Nicolas Tricaud
Journal:  Nat Commun       Date:  2016-07-20       Impact factor: 14.919

9.  Neuronal postdevelopmentally acting SAX-7S/L1CAM can function as cleaved fragments to maintain neuronal architecture in Caenorhabditis elegans.

Authors:  Virginie E Desse; Cassandra R Blanchette; Malika Nadour; Paola Perrat; Lise Rivollet; Anagha Khandekar; Claire Y Bénard
Journal:  Genetics       Date:  2021-08-09       Impact factor: 4.562

10.  Willin, an upstream component of the hippo signaling pathway, orchestrates mammalian peripheral nerve fibroblasts.

Authors:  Susana Moleirinho; Calum Patrick; Andrew M Tilston-Lünel; Jennifer R Higginson; Liselotte Angus; Maciej Antkowiak; Susan C Barnett; Michael B Prystowsky; Paul A Reynolds; Frank J Gunn-Moore
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.